MARKET

BXPHF

BXPHF

Botanix Pharma
OTCPK
0.020
NaN%
Closed 09:30 09/11 EDT
OPEN
--
PREV CLOSE
0.020
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.120
52 WEEK LOW
0.011
MARKET CAP
54.73M
P/E (TTM)
-0.8969
1D
5D
1M
3M
1Y
5Y
1D
Botanix Updates Director Patricia Walker’s Equity Holdings After Option Expiry
TipRanks · 08/31 06:18
Botanix Pharmaceuticals Options Lapse, Streamlining Capital Structure
TipRanks · 08/31 06:17
Botanix Pharm: Strong Sofdra Adoption and Margin Upside Support Buy Rating with Unchanged $1 Price Target
TipRanks · 08/26 18:05
Botanix Revenue Surges on Sofdra Launch as Loss Narrows
TipRanks · 08/26 08:07
Botanix Issues 14 Million Unquoted Performance Rights Under Incentive Plan
TipRanks · 08/14 06:17
Botanix Pharmaceuticals Adds 2.3 Million Shares to ASX Quotation
TipRanks · 08/14 01:49
Botanix Pharmaceuticals Updates Market on Lapsing of 3.25 Million ASX Options
TipRanks · 08/03 04:37
Canaccord Genuity Sticks to Its Buy Rating for Botanix Pharmaceuticals Limited (BOT)
TipRanks · 07/30 00:35
More
About BXPHF
Botanix Pharmaceuticals Limited is an Australia-based dermatology company. The Company’s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).

Webull offers Botanix Pharmaceuticals Ltd stock information, including OTCPK: BXPHF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BXPHF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BXPHF stock methods without spending real money on the virtual paper trading platform.